Low-dose MDCT may locate urinary stone disease, even in overweight patients
April 4th 2007Low-dose multidetector CT (MDCT) that uses a modulated tube current system may be as precise as the standard dose in the detection of urinary stone disease, regardless of the patient&'s weight, Belgian researchers report.
FDA committee: Hormone-refractory PCa agent shows 'substantial evidence' of efficacy, safety
April 4th 2007The FDA’s Office of Cellular, Tissue and Gene Therapies Advisory Committee has recommended to the FDA that there is substantial evidence of efficacy and safety of sipuleucel-T (Provenge) for patients with asymptomatic, metastatic hormone-refractory prostate cancer.
Study identifies unique subgroup of women with SUI
April 1st 2007Among women with stress incontinence and no signs of detrusor overactivity, there exists a significant subgroup with low voided volumes, high incidences of urgency and urge-related leaks, and relatively severe symptoms that can only be identified through careful evaluation.
New nerve stim approach may provide option in OAB
April 1st 2007Dorsal genital nerve stimulation using a minimally invasive, pre-pubic approach appears to reduce the symptoms of overactive bladder and is well tolerated by patients, according to results of a prospective, multicenter feasibility study.
PBS/IC incidence, causes: Studies offer some clues
April 1st 2007Exactly what painful bladder syndrome/interstitial cystitis is, how many people have it, what the risk factors are, what its causes are, what its natural history is, and how it differs from other types of voiding dysfunction in men are questions still looking for answers.
Expectations guide patients' view of incontinence treatment
April 1st 2007Urinary incontinence patients' personal goals and expectations are more closely tied to their quality of life than is any objective measure of the disease, suggesting that treatment outcomes should be assessed in a more patient-focused manner.
Biomarker changes may predict bladder cancer outcomes
April 1st 2007Assessment of a set of four apoptosis markers in patients with urothelial-cell carcinoma of the bladder appears helpful for predicting which patients are at elevated risk for disease recurrence and disease-specific mortality after radical cystectomy and bilateral lymphadenectomy.
Experts strive to comprehend IC: What's in a name?
April 1st 2007Bethesda, MD-Concepts of what interstitial cystitis is, what causes it, and how to treat it are changing. That was apparent with the tremendous infusion of new ideas from many specialties here at the 2006 International Symposium: Frontiers in Painful Bladder Syndrome and Interstitial Cystitis, sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases. Whether those concepts can change without changing the name of the disease, however, was a hotly debated question.
Bill would create federal Office of Men’s Health
March 15th 2007Rep. Vito Fossella (R-NY) has proposed federal legislation to create an Office of Men’s Health that would promote research of male-specific medical issues and educate men on how to improve their health. If passed, the new office would be housed in the federal Department of Health and Human Services.
Cryo may be as effective as laparoscopic removal for kidney tumors
March 15th 2007Percutaneous cryoablation of kidney tumors may be as effective as laparoscopy in eligible patients, according to research presented at the Society of Interventional Radiology’s 32nd annual scientific meeting in Seattle.
False-positive PSA results lead to excess worry, sexual dysfunction
March 15th 2007Men with prostate cancer screenings that result in false-positive results are approximately three times as likely to indicate some degree of concern about developing prostate cancer, and are nearly twice as likely to experience impaired sexual function, compared with men with normal results, new research from the University of Iowa, Iowa City, shows.
Seeds vs. prostatectomy: Long- and short-term side effects differ slightly
March 15th 2007For men with prostate cancer, radiation seed implants may yield a better short-term side effect profile than surgery, but surgery may offer slightly better long-term outcomes, new research from French radiation oncologists indicates.
ED after prostate cancer treatment may be underreported
March 1st 2007Las Vegas-Researchers don't agree on how to measure erectile function and dysfunction, making it difficult to determine the effects of prostate cancer treatment on patients' sex lives, said Johns Hopkins researchers who presented a review of 592 articles at the Sexual Medicine Society of North America fall meeting here.
Peyronie's: Researchers give nod to autologous grafts
March 1st 2007Las Vegas- In their first experiences with xenografts for Peyronie's disease, surgeons at the Mayo Clinic in Jacksonville, FL, decided that Surgisis (Cook Biotech Incorporated, West Lafayette, IN) worked better than Tutoplast (IOP, Inc., Costa Mesa, CA), but the surgeons said they still prefer autologous grafts.